Life Sciences Innovation
Britain has a long and proud history of Life Science innovation and is home to some of the world’s most powerful discoveries and developments. The life sciences sector is undergoing a scientific and technological revolution, from the use of AI to discover new drugs, to the mRNA platform for new vaccines and breakthroughs in gene editing, new technologies are transforming the development of new medicines and vaccines to prevent and treat disease.
In October 2024, the UK government published the Industrial Strategy Green Paper, life sciences are one of eight growth sectors that the government has identified to form part of the new ten-year industrial strategy and UK’s commitment to driving economic growth.
There are ambitious plans to modernise the NHS and make it a better innovation partner for academia and industry. The Government has already announced it has secured £400 million of private investment to boost clinical trials, creating 18 new clinical trial hubs across the UK. Around 20% of this funding will also be used to create sustainable manufacturing innovation which will enhance the UK’s global competitiveness. The NHS strategy also includes plans to harness and utilise the UK’s wealth of health data through use of digital data and AI.
Collaboration between academic institutions, funders and industry players is vital for the translation of research into practical applications. More than 5,600 life sciences businesses already operate in the UK, including all of the top 25 global pharmaceutical companies and top 30 global medical technology companies. More than 300,000 people are directly employed in the industry and the UK is also a hub for global talent.
Life Sciences Innovation will discuss the UK Government’s plans to channel significant investment into the UK’s health and life sciences sector to kickstart economic growth and give patients earlier access to new treatments.
This conference will provide the platform for attendees from the NHS, health research communities and prominent members of the life sciences sector to discuss Investment in cutting-edge medicines research, the government’s mission to kickstart economic growth and build an NHS fit for the future by helping create a thriving environment for life sciences in the UK.
Interested in the Event?
Event Speakers.
Event Schedule.
08.00 – 09.30 – Breakfast, registration and networking
09.30 – 09.40 – Chair’s welcome address
Simon Denegri OBE, Executive Director, The Academy of Medical Sciences (Confirmed)
09.40 – 09.55 – Keynote address – Ensuring the UK is the best place to discover and deploy new medicines
Alex Churchill, Deputy Director, Clinical Trials Policy, Department of Health and Social Care (Confirmed)
09.55 – 10.10 – Fast-tracking the next generation of treatments to NHS patients
Julian Beach, Int Executive Director, Healthcare Quality and Access, Medicines and Healthcare products Regulatory Agency (Invited)
10.10 – 10:25 – Headline Sponsor
10:25 – 10.40 – Q&A Panel Debate
10.40 – 11.20 – Refreshments and Networking
11:20 – 11.35 – 11.20 – 11.35 – A 4 nation approach to bring research closer to communities across the UK
Neil Gray MSP, Cabinet Secretary for Health and Social Care, Scottish Government (Confirmed)
11.35 – 11.50 – Capturing the economic potential in life sciences
Carys Thomas, Head of Policy, Research & Development Division, Welsh Government (Confirmed)
11.50 – 12.05 – Population Health Management
Ian Young, Chief Scientific Advisor, Department of Health, Northern Ireland (Confirmed)
12:05 – 12.20 – Q&A panel Debate
12.20 – 12.30 – Movement Break
12.30 – 12.50 – Case Study 1 – Medicines and vaccine manufacturing
12.50 – 13.10 – Case Study 2 – Harnessing data to improve services for patients
13.10 – 13.30 – Case Study 3 – Diagnostics and early intervention
13:30 – 14:30 – Lunch in the Network Surgery
14.30 – 14.50 – Case Study 4 – AI’s Role in Personalised Medicine
14.50 – 15.10 – Case Study 5 – Targeted Therapy in Cancer
15.10 – 15:30 Movement Break & Refreshments
15.30 – 15.45 – Delivering high-quality research that saves and improves lives
Nicola Perrin MBE, Chief Executive, Association of Medical Research Charities (Confirmed)
15.45 – 15.55 – Kickstarting economic growth and improving the UK’s clinical trials
To be confirmed, Director of Research and Development Policy, ABPI (Confirmed)
15.55 – 16.10 – Improving access to innovative medicines
David Furness, Managing Director, The Shelford Group (Confirmed)
16:10 – 16.25 – Q&A Panel Debate
16:25 – 16.30 – Conference Close
Event Sponsors.
In Partnership With
